Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)
Year: 2010
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm101183p
Authors: Jeffrey T. Bagdanoff, Michael S. Donoviel, Amr Nouraldeen, Marianne Carlsen, Theodore C. Jessop, James Tarver, Saadat Aleem, Li Dong, Haiming Zhang, Lakmal Boteju, Jill Hazelwood, Jack Yan, Mark Bednarz, Suman Layek, Iris B. Owusu, Suma Gopinathan, Liam Moran, Zhong Lai, Jeff Kramer, S. David Kimball, Padmaja Yalamanchili, William E. Heydorn, Kenny S. Frazier, Barbara Brooks, Philip Brown, Alan Wilson, William K. Sonnenburg, Alan Main, Kenneth G. Carson, Tamas Oravecz, David J. Augeri
Institution: Lexicon Pharmaceuticals (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W52199435
